PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in Australia
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.427
https://www.valueinhealthjournal.com/article/S1098-3015(11)01989-9/fulltext
Title :
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in Australia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01989-9&doi=10.1016/j.jval.2011.08.427
First page :
A309
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
400